Zanubrutinib Combined With BR in the First-line Treatment of Waldenström's Macroglobulinemia
Clinical trial NCT06942507 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06942507
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-01
- Primary completion
- 2027-04-30
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.